Talk:Secretin

This  level-5 vital article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Autism C‑class Low‑importance This article is within the scope of WikiProject Autism, a collaborative effort to improve the coverage of all aspects of autism and autistic culture on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.AutismWikipedia:WikiProject AutismTemplate:WikiProject AutismAutism articles C This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible. Low This article has been rated as Low-importance on the project's importance scale. Molecular Biology: MCB This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles ??? This article has not yet received a rating on the importance scale. This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

The amino acid sequence of secretin is given here starting at the C terminus and ending at the N terminus, against normal convention to write the sequence from N->C. Is entire sequence backwards? Or did original author/ editor simply switch the COOH/NH2 end labels? —Preceding unsigned comment added by 130.49.146.57 (talk) 03:10, 2 November 2009 (UTC)[reply]

Good catch. The sequence is written in the correct N- to the C-terminus direction (see UniProt P09683, residues 28–54), but the CO₂H/NH₂ end labels were reversed from what they should be. This error has now been corrected. The confusion may have been caused by the fact that the C-terminus is amidated (CO₂H → CONH₂). Boghog (talk) 06:35, 17 September 2010 (UTC)[reply]

I believe it is typical to represent c-terminal amidation by "-NH₂" rather than "-CONH₂" as this would imply that the carbonyl group is not part of the residue's definition. I have changed this. Please advise if this is incorrect. For example, see "davalintide" in INN list 101. http://www.who.int/medicines/publications/druginformation/innlists/PLFinal101.pdfPeryeat (talk) 21:19, 14 May 2013 (UTC)[reply]

Pretty sure secretin does not DIRECTLY inhibit gastrin secretion (otherwise, how do you explain ZES which is essentially an XS of G cells?). Instead, its inhibitory function is mediated via somatostatin. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC370446/ Normally, somatostatin inhibition exceeds the enhancement of gastrin secretion by secretin, but in ZES, this goes out of whack because of the XS of G cells relative to D cells, hence an upward elevation in gastrin with secretin stimulation in ZES. I don't know how to word the above in a concise format.

Source: my GI professor, but I'm sure there are other sources out there e.g. http://www.ncbi.nlm.nih.gov/pubmed/2565843

Jimhsu77479 (talk) 20:02, 17 September 2011 (UTC)[reply]

The article says that secretin has been proposed as a possible treatment for autism based on a hypothetical gut-brain connection, but there's more to it than that. Secretin has been demonstrated to increase activity in the amygdala, a part of the brain dysfunction of which is linked to autism. http://www.autism.com/ARI/newsletter/182/page2.pdf ^[1] --CanuckBC (talk) 08:40, 12 February 2012 (UTC)[reply]

I want to know if it might be a good idea to include a sentence in the introductory paragraph describing that secretin is the "first hormone" to be discovered, as it would be something significant about secretin. Somerandomuser (talk) 16:50, 7 June 2017 (UTC)[reply]